ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. It also manufactures and sells AB5000 circulatory support system for temporary support of acute heart failure patients in profound shock. In addition, the company engages in the research, development, prototyping, and the pre-serial production of a percutaneous expandable catheter pump, which enhances blood circulation from the heart with an external drive shaft.
Take a look at the 1-year chart of ABIOMED (NASDAQ: ABMD) below with added notations:
ABMD has been in an overall uptrend since February. However, the stock has recently stalled, as ABMD has repeatedly hit the same resistance at $120 (blue). The stock is sitting just under that level now. A solid close above the $120 should lead to another leg higher for ABMD.
ATTENTION SUBSCRIBERS!
Join our new Linkedin Group by clicking the link below:
Stock Trading & Investing for Everyone
The Tale of the Tape: ABMD has a 52-week resistance at $120. The possible long position on the stock would be on a breakout above that level with a stop placed under it.
Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.
No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!
Good luck!
Christian Tharp, CMT
Follow me on Twitter: @cmtstockcoach